Screening of West Siberian patients with primary congenital glaucoma for CYP1B1 gene mutations

Primary congenital glaucoma (PСG) is a visual organ pathology that leads to progressive blindness and poor vision in children. Its main cause is an anomaly of the anterior chamber angle. Most cases of PСG are sporadic, but familial cases with an autosomal recessive (predominantly) and autosomal dominant (rare) type of inheritance have been described. Congenital glaucoma is a rare condition (1 case per 10,000–20,000 newborns), but its prevalence is substantially higher (up to 1 case per 250 newborns) in countries where consanguineous marriages are common. Mutations in the CYP1B1 gene, which encodes cytochrome P450 1B1, are the most common cause of autosomal recessive primary congenital glaucoma. This enzyme is known to be involved in retinoic acid metabolism and is necessary for normal eye development. The aim of this work was to assess the polymorphism of the CYP1B1 gene among West Siberian patients with primary congenital glaucoma. Direct automatic Sanger sequencing of exons and adjacent splicing sites of the CYP1B1 gene was carried out in 28 people with the PCG phenotype from a West Siberian region. As a result, in the sample of the white population we examined, pathogenic variants previously described in other ethnic groups were revealed: E387K (rs55989760), R444* (rs377049098), R444Q (rs72549376), and P437L (rs56175199), as well as novel single-nucleotide deletion p.F114Lfs*38 in the CYP1B1 gene. The latter can cause a frame shift, changed amino acid composition, and a formation of truncated in the protein. None of the detected mutations were found in the control sample of ophthalmologically examined individuals without PCG (100 people). Variants R444* (rs377049098) and R444Q (rs72549376) were not found in the general population sample either (576 randomly selected West Siberia residents). All the detected mutations caused the development of the autosomal recessive form of primary congenital glaucoma. The most severe clinical phenotype was observed in carriers of mutations in codon 444 of the gene. Consequently, in children with signs of increased intraocular pressure, molecular genetic analysis of the CYP1B1 gene is advisable for early diagnosis and timely initiation of PCG therapy.

1. Abu-Amero K.K., Osman E.A., Mousa A., Wheeler J., Whigham B., Allingham R.R., Hauser M.A., Al-Obeidan S.A. Screening of CYP1B1 and LTBP2 genes in Saudi families with primary congenital glaucoma: genotype-phenotype correlation. Mol. Vis. 2011;17: 2911-2919.

2. Afzal R., Firasat S., Kaul H., Ahmed B., Siddiqui S.N., Zafar S.N., Shahzadi M., Afshan K. Mutational analysis of the CYP1B1gene in Pakistani primary congenital glaucoma patients: identification of four known and a novel causative variant at the 30 splice acceptor site of intron 2. Congen. Anom. 2019;59(5):152-161. DOI 10.1111/cga.12312.

3. Badawi A.H., Al-Muhaylib A.A., Al Owaifeer A.M., Al-Essa R.S., Al-Shahwan S.A. Primary congenital glaucoma: An updated review. Saudi J. Ophthalmol. 2019;33(4):382-388. DOI 10.1016/j.sjopt.2019.10.002.

4. Chavarria-Soley G., Michels-Rautenstrauss K., Pasutto F., Flikier D., Flikier P., Cirak S., Bejjani B., Winters D.L., Lewis R.A., Mardin C., Reis A., Rautenstrauss B. Primary congenital glaucoma and Rieger’s anomaly: extended haplotypes reveal founder effects for eight distinct CYP1B1 mutations. Mol. Vis. 2006;12:523-531.

5. Chavarria-Soley G., Sticht H., Aklillu E., Ingelman-Sundberg M., Pasutto F., Reis A., Rautenstrauss B. Mutations in CYP1B1 cause primary congenital glaucoma by reduction of either activity or abundance of the enzyme. Hum. Mut. 2008;29(9):1147-1153.

6. Chouiter L., Nadifi S. Analysis of CYP1B1 gene mutations in patients with primary congenital glaucoma. J. Pediatr. Genet. 2017;6:205- 214. https://doi.org/10.1055/s-0037-1602695.

7. Cvekl A., Wang W.L. Retinoic acid signaling in mammalian eye development. Exp. Eye Res. 2009;89(3):280-291. DOI 10.1016/j.exer.2009.04.012.

8. de Melo M.B., Mandal A.K., Tavares I.M., Ali M.H., Kabra M., de Vasconcellos J.P., Senthil S., Sallum J.M., Kaur I., Betinjane A.J., Moura C.R., Paula J.S., Costa K.A., Sarfarazi M., Paolera M.D., Finzi S., Ferraz V.E., Costa V.P., Belfort R. Jr., Chakrabarti S. Genotype-phenotype correlations in CYP1B1-associated primary congenital glaucoma patients representing two large cohorts from India and Brazil. PLoS One. 2015;10(5):e0127147. DOI 10.1371/journal.pone.0127147.

9. Doshi M., Marcus C., Bejjani B.A., Edward D.P. Immunolocalization of CYP1B1 in normal, human, fetal and adult eyes. Exp. Eye Res. 2006;82(1):24-32. DOI 10.1016/j.exer.2005.04.016.

10. Fan B.J., Wiggs J.L. Glaucoma: genes, phenotypes, and new directions for therapy. J. Clin. Investig. 2010;120(9):3064-3072. DOI 10.1172/JCI43085.

11. Gong B., Qu C., Li X., Shi Y., Lin Y., Zhou Y., Shuai P., Yang Y., Liu X., Zhang D., Yang Z. Mutation spectrum of CYP1B1 in Chinese patients with primary open-angle glaucoma. Br. J. Ophthalmol. 2015;99(3):425-430. DOI 10.1136/bjophthalmol-2014-306054.

12. Hadrami M., Bonnet C., Zeitz C., Veten F., Biya M., Hamed C.T., Condroyer C., Wang P., Sidi M.M., Cheikh S., Zhang Q., Audo I., Petit C., Houmeid A. Mutation profile of glaucoma candidate genes in Mauritanian families with primary congenital glaucoma. Mol. Vis. 2019;25:373-381. Published online 2019 Jul 13.

13. Kaur K., Mandal A.K., Chakrabarti S. Primary congenital glaucoma and the involvement of CYP1B1. Middle East Afr. J. Ophthalmol. 2011;18(1):7-16. DOI 10.4103/0974-9233.75878.

14. Klingenberg M. Pigments of rat liver microsomes. Arch. Biochem. Biophys. 1958;75:376-386. DOI 10.1016/0003-9861(58)90436-3.

15. Libby R.T., Smith R.S., Savinova O.V., Zabaleta A., Martin J.E., Gonzalez F.J., John S.W. Modification of ocular defects in mouse developmental glaucoma models by tyrosinase. Science. 2003;299(5612): 1578-1581. DOI 10.1126/science.1080095.

16. Liu Y., Allingham R.R. Molecular genetics in glaucoma. Exp. Eye Res. 2011;93(4):331-339. DOI 10.1016/j.exer.2011.08.007.

17. Lobov S.L., Khasanova R.R., Zagidullina A.S., Zaydullin I.S., Dzhemileva L.U., Khusnutdinova E.K. Analysis mutations CYP1B1 gene in patients of hereditary forms of glaucoma. Medical Genetics. 2017; 16(6):29-35. (in Russian)

18. Mashima Y., Suzuki Y., Sergeev Y., Ohtake Y., Tanino T., Kimura I., Miyata H., Aihara M., Tanihara H., Inatani M., Azuma N., Iwata T., Araie M. Novel cytochrome P4501B1 (CYP1B1) gene mutations in Japanese patients with primary congenital glaucoma. Investig. Ophthalmol. Vis. Sci. 2001;42(12):2211-2216.

19. Melki R., Colomb E., Lefort N., Brézin A.P., Garchon H.J. CYP1B1 mutations in French patients with early-onset primary open-angle glaucoma. J. Med. Genet. 2004;41:647-651. DOI 10.1136/jmg.2004.020024.

20. Micheal S., Siddiqui S.N., Zafar S.N., Florijn R.J., Bikker H., Boon C.J.F., Khan M., Hollander A.I.D., Bergen A. Identification of novel variants in CYP1B1, PITX2, FOXC1, and PAX6 in congenital glaucoma and anterior segment dysgenesis. Investig. Ophthalmol. Vis. Sci. 2017;58:2124.

21. Motushchuk A.E., Grudinina N.A., Rakhmanov V.V., Mandelstam M.Yu., Astakhov Yu.S., Vasiliev V.B. New P369INS mutation in the CYP1B1 gene in a patient with primary congenital glaucoma from St. Petersburg. Scientific Notes of the Pavlov University. 2009; 16(2):88-89. (in Russian)

22. Muskhelishvili L., Thompson P.A., Kusewitt D.F., Wang C., Kadlubar F.F. In situ hybridization and immunohistochemical analysis of cytochrome P450 1B1 expression in human normal tissues. J. Histochem. Cytochem. 2001;49:229-236. DOI 10.1177/002215540104900210.

23. Pajak A., Szafraniec K., Kubinova R., Malyutina S., Peasey A., Pikhart H., Nikitin Y., Marmot M., Bobak M. Binge drinking and blood pressure: cross-sectional results of the HAPIEE study. PLoS ONE. 2013;8(6):e65856. DOI 10.1371/journal.pone.0065856.

24. Plásilová M., Stoilov I., Sarfarazi M., Kádasi L., Feráková E., Ferák V. Identification of a single ancestral CYP1B1 mutation in Slovak Gypsies (Roms) affected with primary congenital glaucoma. J. Med. Genet. 1999;36(4):290-294.

25. Rashid M., Yousaf S., Sheikh S.A., Sajid Z., Shabbir A.S., Kausar T., Tariq N., Usman M., Shaikh R.S., Ali M., Bukhari S.A., Waryah A.M., Qasim M., Riazuddin S., Ahmed Z.M. Identities and frequencies of variants in CYP1B1 causing primary congenital glaucoma in Pakistan. Mol. Vis. 2019;25:144-154.

26. Sambrook J., Russell D.W. Purification of nucleic acids by extraction with phenol:chloroform. Cold Spring Harbor Protocols: Cold Spring Harbor, 2006.

27. Sarfarazi M. Targeted screening for predominant CYP1B1 mutations in primary congenital glaucoma. J. Ophthalmic. Vis. Res. 2018;3(4): 373-375. DOI 10.4103/jovr.jovr_232_18.

28. Sarfarazi M., Stoilov I. Molecular genetics of primary congenital glaucoma. Eye (Lond). 2000;(Pt 3B):422-428. DOI 10.1038/eye.2000.126.

29. Sena D.F., Finzi S., Rodgers K., Del Bono E., Haines J.L., Wiggs J.L. Founder mutations of CYP1B1 gene in patients with congenital glaucoma from the United States and Brazil. J. Med. Genet. 2004; 41(1):e6. DOI 10.1136/jmg.2003.010777.

30. Souma T., Tompson S.W., Thomson B.R., Siggs O.M., Kizhatil K., Yamaguchi S., Feng L., Limviphuvadh V., Whisenhunt K.N., Maurer-Stroh S., Yanovitch T.L., Kalaydjieva L., Azmanov D.N., Finzi S., Mauri L., Javadiyan S., Souzeau E., Zhou T., Hewitt A.W., Kloss B., Burdon K.P., Mackey D.A., Allen K.F., Ruddle J.B., Lim S.H., Rozen S., Tran-Viet K.N., Liu X., John S., Wiggs J.L., Pasutto F., Craig J.E., Jin J., Quaggin S.E., Young T.L. Angiopoietin receptor TEK mutations underlie primary congenital glaucoma with variable expressivity. J. Clin. Investig. 2016;126(7):2575-2587. DOI 10.1172/JCI85830.

31. Stoilov I., Akarsu A.N., Alozie I., Child A., Barsoum-Homsy M., Turacli M.E., Or M., Lewis R.A., Ozdemir N., Brice G., Aktan S.G., Chevrette L., Coca-Prados M., Sarfarazi M. Sequence analysis and homology modeling suggest that primary congenital glaucoma on 2p21 results from mutations disrupting either the hinge region or the conserved core structures of cytochrome P4501B1. Am. J. Hum. Genet. 1998;62(3):573-584. DOI 10.1086/301764.

32. Thau A., Lloyd M., Freedman S., Beck A., Grajewski A., Levin A.V. New classification system for pediatric glaucoma: Implications for clinical care and a research registry. Curr. Opin. Ophthalmol. 2018; 29(5):385-394. DOI 10.1097/icu.0000000000000516.

33. Vasiliou V., Gonzalez F.J. Role of CYP1B1 in glaucoma. Annu. Rev. Pharmacol. Toxicol. 2008;48:333-358. DOI 10.1146/annurev.pharmtox.48.061807.154729.

34. Wang A., Savas U., Stout C.D., Johnson E.F. Structural characterization of the complex between α-naphthoflavone and human cytochrome P450 1B1. J. Biol. Chem. 2011;18;286(7):5736-5743. DOI 10.1074/jbc.M110.204420.

35. Zavyalova L.G., Denisova D.V., Simonova G.I., Orlov P.S., Voevoda M.I. Association of polymorphisms of genes FTO and TCF7L2 with cadiometabolic parameters of the adolescents in Siberia. Bulleten SB RAMS. 2011;31(5):1-13. (in Russian)

36. Zhao Y., Sorenson C.M., Sheibani N., Cytochrome P450 1B1 and primary congenital glaucoma. J. Ophthalmic Vis. Res. 2015;10(1):60- 67. DOI 10.4103/2008-322X.156116.